Situational analysis of varying models of adherence support and loss to follow up rates; Findings from 27 treatment facilities in eight resource limited countries

Tropical Medicine and International Health

Volumn 15, Issue SUPPL. 1, 2010, Pages 76-81

  Etienne, M ^a   Burrows, L ^a   Osotimehin, B ^a   MacHaria, T ^a   Hossain, B ^a   Redfield, R R ^a   Amoroso, A ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Aadherence support; Community health workers; HIV AIDS; Loss to follow up; Resource limited settings

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; COMMUNITY HEALTH WORKER; DISEASE TREATMENT; DRUG PRESCRIBING; HOSPITAL SECTOR; HUMAN IMMUNODEFICIENCY VIRUS; MEDICINE; MULTIVARIATE ANALYSIS; NUMERICAL MODEL; PUBLIC HEALTH;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; AIDS PATIENT; ARTICLE; CARIBBEAN ISLANDS; CD4 LYMPHOCYTE COUNT; CLINICAL EVALUATION; CONTROLLED STUDY; FOLLOW UP; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE FACILITY; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT MONITORING; PROGRAM DEVELOPMENT; PUBLIC HEALTH SERVICE; TREATMENT OUTCOME;

AFRICA; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COMMUNITY HEALTH SERVICES; DEVELOPING COUNTRIES; HIV INFECTIONS; HUMANS; LOST TO FOLLOW-UP; MEDICALLY UNDERSERVED AREA; MEDICATION ADHERENCE; MODELS, ORGANIZATIONAL; RETROSPECTIVE STUDIES; WEST INDIES;

AFRICA; CARIBBEAN ISLANDS;

EID: 77951823777     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2010.02513.x     Document Type: Article

References (29)

1. Amoroso A, Spencer DE Redfield RR (2004) Improving on success: what treating the urban poor in America can teach us about improving antiretroviral programmes in Africa. AIDS 18 (Suppl. 3 S39 S43.
2. Bisson GP Stringer JSA (2009) Lost but not forgotten-the economics of improving patient retention in AIDS treatment programs. PLoS medicine 6, e1000174.
3. Bisson GP, Gaolathe T, Gross R et al. (2008) Overestimates of survival after HAART: implications for global scale-up efforts. PLoS ONE 3, e1725.
4. Braitstein P, Brinkhof MW, Dabis F et al. (2006) Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 367, 817 824.
5. Brinkhof MW, Dabis F, Myer L et al. (2008) Early loss to program in HIV infected patients starting potent antiretroviral therapy in lower-income countries. Bull World Health Organization 86, 559 567 doi :.
6. Bwirire LD, Fitzgerald M, Zachariah R et al. (2008) Reasons for loss to follow-up among mothers registered in a prevention-of-mother-to-child transmission program in rural Malawi. Transactions of the Royal Society of Tropical Medicine and Hygiene 102, 1195 1200.
7. CDC (2006) Facility-based HIV care/ART reporting form instructions. Center for Disease Control and Prevention
8. Etard JF, Ndjaye I, Thierry-Mieg M et al. (2006) Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study. AIDS 20, 1181 1189.
9. Farmer P, Leandre F, Mukherjee JS et al. (2001) Community-based approaches to the treatment of advanced HIV disease, introducing DOT-HAART. Bulletin of the World Health Organization 79, 1145 1151.
10. Ferradini L Leakhena S (2007) Outcomes of Adults Receiving Second-line ART in Médecins Sans Frontières-supported Projects in Resources-limited Countries. Conference on Retroviruses and Opportunistic Infections (CROI), February 25-28 2007
11. Ferradini L, Jeannin A, Pinoges L et al. (2006) Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet 367, 1335 1342.
12. Gross R, Bilker WB, Friedman HM et al. (2001) Effect of adherence to newly initiated antiretroviral therapy on plasma viral load. AIDS 15, 2109 2111.
13. Hofer CB, Schechter M Harrison LH (2004) Factors Associated with Antiretroviral Adherence in Public Clinics in Rio de Janeiro. International Conference on AIDS July 11-16, 2004; 15: abstract no. WeOrB1319.
14. Koenig PS, Riviere C, Leger P et al. (2008) The cost of antiretroviral therapy in Haiti. Cost Effectiveness and Resource Allocation 6, 3.
15. Lanoy E, Mary-Krause M, Tattevin P et al. (2006) Predictors identified for losses to follow-up among HIV-seropositive patients. Journal of Clinical Epidemiology 59, 829 835.
16. Lawn SD, Myer L, Orrell C, Bekker LG Wood R (2005) Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS 19, 2141 2148.
17. Losina E, Touré H, Uhler LM et al. (2009) Cost-Effectiveness of Preventing Loss to Follow-up in HIV Treatment Programs: A Côte d'Ivoire Appraisal. PLoS Med 6 (10 e10000173. doi :.
18. Lucas GM, Chaisson RE Moore RD (1999) Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Annals of Internal Medicine 131, 81 87.
19. Martin W, Brinkhof G, Dabis F et al. (2008) Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bulletin of the World Health Organization 86, 497 576.
20. Mukherjee JS, Ivers L, Leandre F, Farmer P Behforouz H (2006) Antiretroviral therapy in resource-poor settings decreasing barriers to access and promoting adherence. Journal of Acquired Immune Deficiency Syndrome 43, S123 S126.
21. Rosen S, Fox MP Gill CJ (2007) Patient retention in antiretroviral therapy programs in Sub-Saharan Africa: a systematic review. PLoS Med 4 (10 e298. doi :.
22. Schneider H et al. (2007) Can the Public Sector Rise to the Challenge of ART? Evidence from Second Generation Sites in Gauteng Province. Third South African AIDS Conference, Durban, abstract 474.
23. Severe P, Leger P, Charles M et al. (2005) Antiretroviral therapy in a thousand patients with AIDS in Haiti. New England Journal of Medicine 353, 749 751.
24. UNAIDS/WHO/UNICEF (2008a) Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector. WHO
25. UNAIDS/WHO/UNICEF (2008b) Nearly Three Million HIV-Positive People Now Receiving Life-Saving Drugs. WHO Media release
26. Variava E (2007) Reasons for Loss to Follow-Up and Defaulter Tracing After 2 years of ART Programme. Third South African AIDS Conference, Durban, abstract 590 2007.
27. Walton D, Farmer P, Lambert W et al. (2004) Integrated HIV prevention and care strengthens primary health care: lessons from rural Haiti. Journal of Public Health Policy 25, 137 158.
28. WHO (2006) Treating 3 Million by 2005: Making it Happen. WHO
29. Wools-Kaloustian K Kimaiyo S (2006) Extending HIV care in resource-limited settings. Current HIV/AIDS Report 4, 182 186.